POLAHIST Dexchlorpheniramine maleate 2 mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

dexchlorpheniramine maleate, Quantity: 2 mg

Available from:

Bioinnova Pty Ltd

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: purified water; magnesium stearate; lactose monohydrate; maize starch; pregelatinised starch

Administration route:

Oral

Units in package:

20 tablets, 40 tablets

Prescription type:

(S3) Pharmacist Only Medicine

Therapeutic indications:

For the symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. It may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and drug reactions, including serum sickness.

Product summary:

Visual Identification: White, round, flat, uncoated tablets, scored on one side &plain on other side.; Container Type: Blister Pack; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2021-11-16